Hyperinsulinemia and central adiposity: Influence of chronic insulin therapy in type 1 diabetes [6]

Diabetes Care

Volumn 23, Issue 7, 2000, Pages 1024-1025

  Kabadi, Udaya M ^a,b   Vora, Ameet ^a   Kabadi, Mary ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BODY MASS; DISEASE ASSOCIATION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LETTER; LIPID STORAGE; LIPOGENESIS; MAJOR CLINICAL STUDY; OBESITY;

EID: 0033911918     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.7.1024     Document Type: Letter

References (7)

1. Ferrannini E, Camastra S: Relationship between impaired glucose tolerance, non-insulin-dependent diabetes mellitus and obesity. Eur J Clin Invest 28 (Suppl. 2):3-6, 1998
2. Karter AJ, Mayer-Davis EJ, Selby JV, D'Agostino RB Jr. Haffner SM, Sholinsky P, Bergman R, Saad MF, Hamman RF: Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women: the Insulin Resistance and Atherosclerosis Study. Diabetes 45:1547-1555, 1996
3. Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M, Alberti KG: Social inequality in coronary risk: central: obesity and the metabolic syndrome, evidence from the Whitehall II study. Diabetologia 40:1341-1349, 1997
4. Diabetes Control and Complications Trial Research Group: Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 18:1415-1427, 1995
5. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD: Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT: Diabetes Control and Complications Trial. JAMA 280:140-161, 1998
6. U.K. Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
7. U.K. Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998